vial tirzepatide 149.00 | --- 27 mg / 3 ml --- 3 ml --- Weight Loss Glucagon-Like Peptide-1 (GLP-1) 1 and GIP therapy Compounded GLP-1 - Semaglutide &

Because Wegovy is a self-administered injectable drug, coverage will be provided under Part D, Medicares outpatient drug benefit offered by private stand-alone drug plans and Medicare Advantage plans, not Part B, which covers physician-administered drugs

GLP-1 plays a multifaceted role in weight management by regulating appetite, stabilizing blood sugar, and influencing fat metabolism

No therapeutic, physiological or clinical outcome is represented

2i,j), suggesting that this response is independent of oncogenic driver mutation and culture conditions 22

Studies show reduced hydrolysis rates compared to room temperature storage

PP2A specifically dephosphorylates Beclin-1 at Ser90, whereas AMPKactivated under energy stressphosphorylates ULK1 to initiate autophagy, and targets Beclin-1 at Ser91/Ser94 residues (Kim et al., 2013